Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
As an organization whose mission is to improve cancer care globally, NCCN stands in solidarity with the Ukrainian people.
Clinical testing of this approach in people with ovarian cancer is expected to start later this year.
A vaccine designed to enhance T-cell activity could help CAR-T therapy work better against solid tumors.
A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.
There are many ways to get smarter in this issue.
Tragedy may have saved her life.
New clues help explain why only 10-15% of ovarian cancer patients respond favorably to immune checkpoint inhibitor therapy.
For some people with access to skilled surgeons, surgery plus chemotherapy improves survival compared to chemotherapy alone.
Erin Cronican, who has metastatic breast cancer, stars in a new production of Wit, a play about a woman dying of metastatic ovarian cancer.
The Dana-Farber Cancer Institute answers your common questions about testing for mutations in BRCA genes associated with cancer.
Researchers looking at ovarian cancer cells that resist chemotherapy hope to develop new therapeutic strategies.
The diagnosis spurred the television icon to emphasize the importance of early detection when it comes to ovarian cancer.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
Higher rates of anxiety and depression are associated with higher mortality risk among women with ovarian cancer.
Using birth control correlates to a small increase in breast cancer risk but a larger, permanent drop in ovarian and endometrial cancer.
But not bearing children appears to do so.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.